AuntMinnieEurope.com staff writersClinical NewsIBA lands Russian orderRadiopharmaceutical firm Ion Beam Applications (IBA) has received a proton therapy center order from the Federal Medico-Biological Agency of Russia.October 12, 2010Clinical NewsSiemens targets breast cancer awarenessSiemens Healthcare is launching a breast cancer awareness program.October 12, 2010Molecular ImagingGE adds to molecular imaging lineGE Healthcare is highlighting a number of new developments with its molecular imaging portfolio at this week's European Association of Nuclear Medicine congress in Vienna.October 11, 2010Clinical NewsPETNet opens new biomarker facilitySiemens Healthcare subsidiary PETNet Solutions has opened an imaging biomarker production facility in Madrid.October 10, 2010Clinical NewsPETNet expands biomarker productionPETNet Solutions is expanding its imaging biomarker production capabilities in Nottingham, England, to enhance its ability to produce new biomarkers as investigational medicine products in the U.K.October 7, 2010Clinical NewsMDS Nordion touts TheraSphere studyMDS Nordion announced that the first large European study using yttrium-90 glass microspheres has been published on the use of TheraSphere, a radioembolization therapy for the localized treatment of advanced hepatocellular carcinoma or primary liver cancer.October 7, 2010Clinical NewsSiemens debuts HD-Chest for PET/CTSiemens Healthcare has introduced HD-Chest, a new technology designed to reduce blur created by respiration during PET/CT studies.October 7, 2010Clinical NewsMirada upgrades XD3 softwareMedical imaging software developer Mirada Medical has announced that its latest XD3 multimodality image fusion analysis package is now available as an option for users of PACS software from Sectra.October 4, 2010Clinical NewsNorwegian researcher launches DBT studyA Norwegian researcher has launched a study that will compare the performance of digital breast tomosynthesis (DBT) to conventional digital mammography, according to a Norwegian hospital.October 3, 2010Clinical NewsFLT-PET technique targets ovarian cancerA molecular imaging technique that uses F-18 fluorothymidine (FLT) may prove useful in the early assessment of treatment response for cisplatin-resistant ovarian cancer, according to a study in the October issue of the Journal of Nuclear Medicine.October 3, 2010Previous PagePage 814 of 934Next PageTop StoriesMolecular ImagingNeuroinflammation persists for 2 years in long COVIDA Dutch team has used PET to reveal neuroinflammation in patients with persistent severe fatigue and difficulty concentrating more than two years after COVID-19 infection.MRIChatGPT gathers momentum in MR imagingCTLow-dose CT ties emphysema to mortality in previous smokersMRIKeep calm: Booklets aim to conquer children's anxietySponsor Content"Join Us"
